BETHESDA, Md. (Nov. 21, 2024) Naval Medical Research Unit’s (NMRC) Clinical Trial Center (CTC) is preparing to conduct a phase 1 clinical trial for a Staphylococcus aureus vaccine, aimed at reducing frequency and severity of infections caused by Staph aureus, a leading cause of skin and soft tissue infections. NMRC is engaged in a broad spectrum of medical research, from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of the Navy, Marine Corps and joint U.S. warfighters, NMRC researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, medical modeling, simulation, operational mission support, epidemiology and behavioral sciences. (U.S. Navy photo by Tommy Lamkin/Released)
| Date Taken: | 11.21.2024 |
| Date Posted: | 12.20.2024 11:42 |
| Photo ID: | 8811605 |
| VIRIN: | 241121-N-UM734-1013 |
| Resolution: | 6720x4480 |
| Size: | 2.28 MB |
| Location: | BETHESDA, MARYLAND, US |
| Web Views: | 67 |
| Downloads: | 13 |
This work, NMRC CTC Performs Clinical Vaccine Trials [Image 2 of 2], by Tommy Lamkin, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
NMRC Researchers Conduct First in Human Clinical Trials for Staph A Treatment
No keywords found.
